Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 2

ABSTRACT: Systematic meta-analysis and replication of genome-wide expression studies identifies molecular pathways of Parkinson's disease. Examination of substantia nigra from postmortem brains of 8 patients with Parkinson's disease (PD). The substantia nigra samples from 8 PD subjects were obtained from the Human Brain and Spinal Fluid Resource Center, VAMC, Los Angeles, CA, the Mind Unit Brain Bank at the University of Rochester, Rochester, NY, and from Dr. E. Masliah at UCSD, San Diego, CA, and 9 control subjects were obtained from the University of Rochester Alzheimer's Disease Center brain bank. The RNA was extracted using Trizol reagent (Invitrogen), DNAse treated with Qiagen DNAse, and analyzed on a bioanalyzer. The complementary RNA was fragmented and hybridized to Affymetrix human U133A arrays. The total 17 Affymetrix .CEL files were normalized to "all probe sets" in a standardized matter, and scaled to 100 by the MAS5 algorithm implemented in the Bioconductor package.

ORGANISM(S): Homo sapiens

SUBMITTER: Bin Zheng 

PROVIDER: E-GEOD-20163 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Zheng Bin B   Liao Zhixiang Z   Locascio Joseph J JJ   Lesniak Kristen A KA   Roderick Sarah S SS   Watt Marla L ML   Eklund Aron C AC   Zhang-James Yanli Y   Kim Peter D PD   Hauser Michael A MA   Grünblatt Edna E   Moran Linda B LB   Mandel Silvia A SA   Riederer Peter P   Miller Renee M RM   Federoff Howard J HJ   Wüllner Ullrich U   Papapetropoulos Spyridon S   Youdim Moussa B MB   Cantuti-Castelvetri Ippolita I   Young Anne B AB   Vance Jeffery M JM   Davis Richard L RL   Hedreen John C JC   Adler Charles H CH   Beach Thomas G TG   Graeber Manuel B MB   Middleton Frank A FA   Rochet Jean-Christophe JC   Scherzer Clemens R CR  

Science translational medicine 20101001 52

Parkinson's disease affects 5 million people worldwide, but the molecular mechanisms underlying its pathogenesis are still unclear. Here, we report a genome-wide meta-analysis of gene sets (groups of genes that encode the same biological pathway or process) in 410 samples from patients with symptomatic Parkinson's and subclinical disease and healthy controls. We analyzed 6.8 million raw data points from nine genome-wide expression studies, and 185 laser-captured human dopaminergic neuron and sub  ...[more]

Similar Datasets

Transcriptomics Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 3
2011-01-20 | E-GEOD-20164 | biostudies-arrayexpress
Unknown Next generation sequencing reveals upregulation of the lncRNA LINC-PINT in the substantia nigra of human Parkinson's disease patients compared to control donors
2020-04-14 | GSE114517 | GEO
Unknown Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 3
2011-01-20 | GSE20164 | GEO
Transcriptomics System-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms
2014-09-01 | E-GEOD-54282 | biostudies-arrayexpress
Unknown Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 2
2011-01-20 | GSE20163 | GEO
Unknown Dietary intake of α-ketoglutarate ameliorates α-synuclein pathology in a Parkinson’s disease mouse model
2022-10-02 | GSE214446 | GEO
Unknown Transcriptomic profiling of substantia nigra and putamen in Parkinson’s disease
2020-09-02 | GSE136666 | GEO
Transcriptomics Transcription profiling of human Parkinsons medial and substania nigra
2008-06-16 | E-GEOD-8397 | biostudies-arrayexpress
Unknown Exploring transcriptome-wide changes in the brain-localized immune cells in a mouse model of Parkinson's Disease
2021-11-01 | GSE148784 | GEO
Unknown Aberrant striatal but not nigral gene expression profiles are specifically associated with dyskinesia behavior following levodopa treatment in the 6-hydroxydopamine lesioned rat
2017-10-31 | GSE88726 | GEO